CN103800690B - 一种龙血树叶、石斛药物组合物及其制备方法、制剂和应用 - Google Patents
一种龙血树叶、石斛药物组合物及其制备方法、制剂和应用 Download PDFInfo
- Publication number
- CN103800690B CN103800690B CN201410057752.1A CN201410057752A CN103800690B CN 103800690 B CN103800690 B CN 103800690B CN 201410057752 A CN201410057752 A CN 201410057752A CN 103800690 B CN103800690 B CN 103800690B
- Authority
- CN
- China
- Prior art keywords
- herba dendrobii
- draconiss
- sanguis
- leaveves
- micropowders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 84
- 239000003814 drug Substances 0.000 claims abstract description 37
- 239000002245 particle Substances 0.000 claims abstract description 21
- 238000004140 cleaning Methods 0.000 claims abstract description 13
- 239000002671 adjuvant Substances 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 36
- 238000000227 grinding Methods 0.000 claims description 25
- 210000002966 serum Anatomy 0.000 claims description 17
- 241000292342 Dracaena cochinchinensis Species 0.000 claims description 14
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 238000010298 pulverizing process Methods 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 9
- 238000002347 injection Methods 0.000 claims description 9
- 239000007924 injection Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 241001523681 Dendrobium Species 0.000 claims description 8
- 239000000186 progesterone Substances 0.000 claims description 7
- 229960003387 progesterone Drugs 0.000 claims description 7
- OBRNDARFFFHCGE-QDSVTUBZSA-N arformoterol fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1 OBRNDARFFFHCGE-QDSVTUBZSA-N 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 241001306121 Dracaena <Squamata> Species 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims description 3
- UXDFUVFNIAJEGM-UHFFFAOYSA-N 2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethyl]phenol Chemical compound C1=C(O)C(OC)=CC=C1CCC1=CC(OC)=C(OC)C(OC)=C1 UXDFUVFNIAJEGM-UHFFFAOYSA-N 0.000 claims description 3
- 241000026010 Dendrobium candidum Species 0.000 claims description 3
- 244000283926 Dendrobium chrysotoxum Species 0.000 claims description 3
- 229960005309 estradiol Drugs 0.000 claims description 3
- 229930182833 estradiol Natural products 0.000 claims description 3
- 229960000193 formoterol fumarate Drugs 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 244000030990 Dendrobium fimbriatum Species 0.000 claims description 2
- 241000229499 Dendrobium loddigesii Species 0.000 claims description 2
- 240000004638 Dendrobium nobile Species 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 14
- 229940079593 drug Drugs 0.000 abstract description 9
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 238000004090 dissolution Methods 0.000 abstract description 2
- 241000700159 Rattus Species 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 241000700199 Cavia porcellus Species 0.000 description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 12
- 239000008103 glucose Substances 0.000 description 12
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 210000002421 cell wall Anatomy 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 210000005075 mammary gland Anatomy 0.000 description 5
- 210000002445 nipple Anatomy 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 description 4
- 102100030797 Conserved oligomeric Golgi complex subunit 2 Human genes 0.000 description 4
- 101000920113 Homo sapiens Conserved oligomeric Golgi complex subunit 2 Proteins 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000004575 stone Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000037396 body weight Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 229950002007 estradiol benzoate Drugs 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 3
- 229960001008 heparin sodium Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- -1 alcohol compound Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000009136 dragon's blood Substances 0.000 description 2
- 229940000406 drug candidate Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003777 experimental drug Substances 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 2
- 229960001052 streptozocin Drugs 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- NHUFMXNVSAWNTO-OJUPNBFJSA-N (3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O.OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O NHUFMXNVSAWNTO-OJUPNBFJSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 244000248349 Citrus limon Species 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000723363 Clerodendrum Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000004131 Iresine herbstii Nutrition 0.000 description 1
- 241001453150 Iresine rhizomatosa Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000008508 epithelial proliferation Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000008376 fluorenones Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 150000002772 monosaccharides Chemical group 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 230000001936 parietal effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410057752.1A CN103800690B (zh) | 2014-02-20 | 2014-02-20 | 一种龙血树叶、石斛药物组合物及其制备方法、制剂和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410057752.1A CN103800690B (zh) | 2014-02-20 | 2014-02-20 | 一种龙血树叶、石斛药物组合物及其制备方法、制剂和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103800690A CN103800690A (zh) | 2014-05-21 |
CN103800690B true CN103800690B (zh) | 2017-03-08 |
Family
ID=50698385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410057752.1A Active CN103800690B (zh) | 2014-02-20 | 2014-02-20 | 一种龙血树叶、石斛药物组合物及其制备方法、制剂和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103800690B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104705442A (zh) * | 2015-03-31 | 2015-06-17 | 吴绍平 | 铁皮石斛茶及其制备方法 |
CN105343366A (zh) * | 2015-12-11 | 2016-02-24 | 普洱淞茂制药股份有限公司 | 一种药物组合物及其制备方法、制剂与应用 |
CN106668441A (zh) * | 2017-02-27 | 2017-05-17 | 普洱淞茂滇草六味制药股份有限公司 | 一种龙血树叶的应用 |
CN112439506B (zh) * | 2021-01-29 | 2021-05-18 | 浙江铁枫堂药业有限公司 | 一种基于铁皮石斛粉制备的智能研磨设备 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103301322A (zh) * | 2013-06-01 | 2013-09-18 | 普洱淞茂制药股份有限公司 | 一种石斛超微纯粉及其制备方法与制剂 |
CN103316194A (zh) * | 2013-06-01 | 2013-09-25 | 普洱淞茂制药股份有限公司 | 一种龙血树叶超微纯粉及其制备方法与制剂 |
-
2014
- 2014-02-20 CN CN201410057752.1A patent/CN103800690B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103301322A (zh) * | 2013-06-01 | 2013-09-18 | 普洱淞茂制药股份有限公司 | 一种石斛超微纯粉及其制备方法与制剂 |
CN103316194A (zh) * | 2013-06-01 | 2013-09-25 | 普洱淞茂制药股份有限公司 | 一种龙血树叶超微纯粉及其制备方法与制剂 |
Non-Patent Citations (1)
Title |
---|
滇草6味·龙血树叶粉(袋泡);ynsmyy;《普洱淞茂医药集团》;20131204;龙血树叶+石斛=治疗乳腺增生、糖尿病 项 * |
Also Published As
Publication number | Publication date |
---|---|
CN103800690A (zh) | 2014-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10086032B2 (en) | Method for preparing a Camellia nitidissima Chi lipid-lowering and hypoglycemic agent | |
CN102631377B (zh) | 冬虫夏草冻干纳米粉片及其制备方法 | |
CN105999159B (zh) | 一种黑糖雪莲组合物及其制备方法 | |
CN103800690B (zh) | 一种龙血树叶、石斛药物组合物及其制备方法、制剂和应用 | |
CN101002906A (zh) | 一种中药复方及其用途 | |
CN104739777A (zh) | 一种单味中药粉末的制备方法 | |
CN105560884A (zh) | 一种治疗狗肺炎的药物组合物及其制备方法 | |
CN1275639C (zh) | 一种治疗妇科习惯性流产和先兆性流产疾病的药物及其制备方法 | |
CN102319398B (zh) | 一种和血明目中药组合物及其制备方法 | |
CN102188520B (zh) | 一种治疗脑缺血的中药组合物及其应用 | |
CN104940781A (zh) | 一种用于治疗白脉病的藏药组合物及其制备方法 | |
CN106138282A (zh) | 一种用于糖尿病人调脂降压的雅连冲剂及其制备方法 | |
CN102727793B (zh) | 一种益坤宁药物组合物固体脂质纳米粒制剂 | |
CN1899415B (zh) | 一种治疗慢性肝病的中药复方制剂及其制备方法 | |
CN109224038A (zh) | 一种治疗瘀血阻络型肝纤维化的含引经药吴茱萸的中药组合物及其制备方法和应用 | |
CN104474195A (zh) | 一种治疗白癜风的中药复方制剂及其制备方法 | |
CN104056159B (zh) | 艳山姜挥发油滴丸及其制备方法 | |
CN102716424B (zh) | 一种治疗乳癖的药物组合物及其制备方法和用途 | |
CN105998697A (zh) | 一种治疗食道癌的药物组合物 | |
CN102028834A (zh) | 一种复方龙血竭制剂及其制备方法 | |
CN101264241B (zh) | 一种治疗妇科疾病的药物组合物及制备方法 | |
CN102008565B (zh) | 一种治疗溃疡性结肠炎的药物组合物及其制备方法 | |
CN105853366B (zh) | 青阳参总甙固体分散体及其制剂 | |
CN1994330B (zh) | 一种动物类中药材的粉碎方法 | |
CN101204509A (zh) | 一种中药软胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 665000 Yunnan province city Simao district is the wood River Industrial Park Patentee after: PUER SONGMAO DIANCAO LIUWEI PHARMACEUTICAL CO.,LTD. Address before: 665000 Simao province Yunnan city Simao District of Puer City wood is the River Industrial Park Patentee before: PUER SONGMAO PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A combination of dragon blood leaves and dendrobium medicinal materials, its preparation method, formulation, and application Granted publication date: 20170308 Pledgee: Yunnan Pu'er Simao Rural Commercial Bank Co.,Ltd. Pledgor: PUER SONGMAO DIANCAO LIUWEI PHARMACEUTICAL CO.,LTD. Registration number: Y2024980030087 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |